In conclusion, our work suggested that defining the molecular basis of splicing and regulation of ARHGEF11 and other molecules will provide critical new insight into the invasive properties of breast cancer and provide new avenues for novel therapeutic interventions for treatment of patients in the future. The gene discussed is ARHGEF11; the disease is breast cancer.